Brinzolamide 1/timolol versus dorzolamide 2/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study

摘要

PurposeThe objective of this study was to assess preference for fixed-combination brinzolamide 1%/timolol 0.5% (BTFC) versus fixed-combination dorzolamide 2%/timolol 0.5% (DTFC) in patients with open-angle glaucoma or ocular hypertension.